ICP
Interchange Capital Partners Portfolio holdings
AUM
$433M
This Quarter Return
+20.19%
1 Year Return
+16.43%
3 Year Return
+67.58%
5 Year Return
–
10 Year Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$184M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
18.84%
Holding
1,232
New
1,230
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
iShares Gold Trust
IAU
|
$4.78M |
| 2 |
Apple
AAPL
|
$4.74M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
$4.17M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$3.92M |
| 5 |
Vanguard Value ETF
VTV
|
$3.76M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 15.68% |
| 2 | Healthcare | 13.87% |
| 3 | Consumer Discretionary | 9.11% |
| 4 | Financials | 7.58% |
| 5 | Communication Services | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Serina Therapeutics
SER
$54.5M
| $0 | ﹤0.01% |
+400
| New | – |
|
|
CPE
1227
DELISTED
Callon Petroleum Company
CPE
| $0 | ﹤0.01% |
+2
| New | – |
|
|
MNRL
1228
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $0 | ﹤0.01% |
+83
| New | – |
|
|
HYMCZ
1229
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
| $0 | ﹤0.01% |
+1
| New | – |
|
|
ODT
1230
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $0 | ﹤0.01% |
+18
| New | – |
|
|
BMY.RT
1231
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $0 | ﹤0.01% |
+21
| New | – |
|
|
PSXP
1232
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $0 | ﹤0.01% |
+19
| New | – |
|